Increased risk of breast cancer in women with NF1

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 12, 2012, Pages 3056-3060

  Madanikia, Sara Aileen ^a   Bergner, Amanda ^b   Ye, Xiaobu ^b   Blakeley, Jaishri O'Neill ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Breast neoplasms; Historical cohort study; Neurofibromatosis 1; SEER program

Indexed keywords

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NEUROFIBROMATOSIS; PRIORITY JOURNAL; RACE; STANDARDIZED INCIDENCE RATIO; UNITED STATES;

EID: 84870244257     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35550     Document Type: Article

References (22)

1. Ardern-Holmes SL, North KN. 2011. Therapeutics for childhood neurofibromatosis type 1 and type 2. Curr Treat Options Neurol 13: 529-543.
2. Aziz H, Hussain F, Sohn C, Mediavillo R, Saitta A, Hussain A, Brandys M, Homel P, Rotman M. 1999. Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol 22: 436-440.
3. Brems H, Beert E, de Ravel T, Legius E. 2009. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 10: 508-515.
4. Brunetti-Pierri N, Doty SB, Hicks J, Phan K, Mendoza-Londono R, Blazo M, Tran A, Carter S, Lewis RA, Plon SE, et al. 2008. Generalized metabolic bone disease in neurofibromatosis type I. Mol Genet Metab 94: 105-111.
5. El-Tamer MB, Wait RB. 1999. Age at presentation of African-American and Caucasian breast cancer patients. J Am Coll Surg 188: 237-240.
6. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. 2002. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39: 311-314.
7. Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F. 2010. Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service. Am J Med Genet Part A 152A: 327-332.
8. Evans DG, O'Hara C, Wilding A, Ingham SL, Howard E, Dawson J, Moran A, Scott-Kitching V, Holt F, Huson SM. 2011. Mortality in neurofibromatosis 1: In North West England: An assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet 19: 1187-1191.
9. Huson SM, Harper PS, Compston DA. 1988 Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 111: 1355-1381.
10. Jondeau G, Michel JB, Boileau C. 2011. The translational science of Marfan syndrome. Heart 97: 1206-1214.
11. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, et al. 2009. Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms. Ann Intern Med 151: 738-747.
12. Montani D, Coulet F, Girerd B, Eyries M, Bergot E, Mal H, Biondi G, Dromer C, Hugues T, Marquette C, et al. 2011. Pulmonary hypertension in patients with neurofibromatosis type I. Medicine (Baltimore) 90: 201-211.
13. National Institutes of Health Consensus Development Conference. 1988. Neurofibromatosis. Conference statement. Arch Neurol 45: 575-578.
14. Riccardi VM. 2010. Neurofibromatosis type 1 is a disorder of dysplasia: The importance of distinguishing features, consequences, and complications. Birth Defects Res A Clin Mol Teratol 88: 9-14.
15. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, et al. 2007. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57: 75-89.
16. SEER. 2011 [Internet] Bethesda, MD: National Cancer Institute; [updated 2011 October 6; cited 2011 October 9]. Available from: http://seer.cancer.gov.
17. Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E, Evans DG. 2007. Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 44: 481-484.
18. Shirley ED, Sponseller PD. 2009. Marfan syndrome. J Am Acad Orthop Surg 17: 572-581.
19. Silverstein MD, Nietert PJ, Ye X, Lackland DT. 2003. Racial disparities in the incidence of lung cancer: The Savannah River region health information system cancer registry, 1991-95. J Health Care Poor Underserved 14: 23-33.
20. US Preventive Services Task Force. 2009. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 151: 716-726, W-236.
21. Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I, Baralle D. 2006. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer 95: 233-238.
22. Wilson CH, Griffith CD, Shrimankar J, Douglas F. 2004. Gynaecomastia, neurofibromatosis and breast cancer. Breast 13: 77-79.